Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out how well patients with cancer of the rectum do if
they get all of their other treatment - chemotherapy by itself followed by chemotherapy and
radiation together - before surgery. Patients have recently been diagnosed with rectal
cancer, and the doctors have recommended neo-adjuvant chemo treatment to try to shrink the
cancer before removing it.
Phase:
Phase 2
Details
Lead Sponsor:
William Sikov William Sikov MD
Collaborators:
Memorial Hospital of Rhode Island Rhode Island Hospital The Miriam Hospital